What you need to know about Australia and New Zealand Banking Group's half-year result

Shares are down despite a strong result. So is now the time to buy?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today, Australia and New Zealand Banking Group (ASX: ANZ) released its half-year report, which showed some impressive signs of growth. Here are the highlights, compared to the previous corresponding half in 2013:

  • Cash profit of $3.5 billion, up 11%
  • Interim dividend of 83 cents per share, up 14%
  • Return on equity flat at 15.5%
  • Net interest margin of 2.15% (down from 2.24%)
  • Customer deposits up 13%, net loans and advances up 12%
  • Provision charge (for bad and doubtful debts) of $528 million, down 12%

Commenting on today's results, CEO Mike Smith said, "This is a good set of results. They demonstrate consistent progress with ANZ's long-term strategy to grow in our core franchises in Australia and New Zealand, to build a significant and profitable franchise in Asia Pacific, and to establish common infrastructure and processes that improve productivity and reduce risk."

Shares down in early trade

Despite what appears to be a strong report, ANZ shares have followed its rivals lower in early trade this morning. It seems investors wanted more than 11% profit growth from this $95 billion company.

Digging deeper

Today's result showed a number of very promising signs for both ANZ management and its shareholders. Perhaps most impressive was the progress of the group's long-term Super Regional Strategy which enabled the bank's Asia, Pacific, Europe and Americas (APEA) markets to grow profits 43% as a result of increased customer numbers and demand for regional trade and investment products. The stellar result means the APEA markets account for more than 19% of the (FX-adjusted) cash profit for the entire bank.

Mr Smith acknowledged the bank's international performance saying: "Our international business, particularly Asia, is firing on all cylinders with revenue and profits again growing strongly, and a sustained improvement in returns… Since we launched our strategy six years ago, the compound annual growth rate in earnings from Asia has been 37%, and ANZ is now being consistently rated a top four Corporate Bank in Asia by Greenwich Associates."

The International and Institutional Banking (IIB) division grew profit 9% with income up 4% and expenses up 3%, along with further credit quality improvements which resulted in provisions down 18%. 52% of its earnings now come from outside Australia and New Zealand. Inside IIB, demand for a number of products including Foreign Exchange, Cash Management deposits and Supply Chain was strong. Total customers grew 12%.

Closer to home, the bank's Australia division felt the benefits of consistent mortgage portfolio growth and grew profit 5%. Lending grew 6% with customer deposits up 7%. Small business lending was the standout performer, up 16%.

In New Zealand, profit grew 21% as market share, productivity and credit quality improved. Lending grew 5% with deposits up 7%.

The Global Wealth division saw profit rise 11% with operating income up 8% and expenses up 7%. Funds under management and insurance continued their strong performance.

At March 31, the bank's APRA Common Tier One ratio stood at 8.33% or 10.5% on an internationally harmonised Basel 3 basis. Down from 8.5% in the previous half.

Foolish takeaway

Analysts have, for some time, been calling the banks' overpriced or fairly valued. I agree. Today's result and subsequent reaction of the market says it all: some investors were expecting more.

In my opinion ANZ is the best big bank and will grow at a faster pace than each of its main rivals including Commonwealth Bank of Australia (ASX: CBA), National Australia Bank Ltd. (ASX: NAB) and Westpac Banking Corp (ASX: WBC), simply because of its diversified earnings and growth in Asia.

Foolish (capital 'F') long-term investors know the best time to buy a stock is when it's cheapest and currently ANZ is not the cheapest it's likely to be if bad debts and interest rates rise. Although today's result was in line with my expectations I still don't believe the current price is justified. As such, although I really like ANZ, I'll be steering clear of it for now.

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »